Profil
Jeff Macdonald is currently Executive Director-Investor Relations at Jazz Pharmaceuticals Plc and will hold the same title at Vaxcyte, Inc. starting in 2025.
Former roles include Senior Director-Corporate Communications at Acorda Therapeutics, Inc. and Senior Director-Investor Relations at G1 Therapeutics, Inc. from 2018 to 2021.
Education includes an undergraduate degree from Washington & Lee University.
Aktive Positionen von Jeff Macdonald
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Investor Relations Kontakt | - |
| VAXCYTE, INC. | Investor Relations Kontakt | 01.06.2025 |
Ehemalige bekannte Positionen von Jeff Macdonald
| Unternehmen | Position | Ende |
|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Kontakt | 04.01.2021 |
| ACORDA THERAPEUTICS, INC. | Investor Relations Kontakt | 10.05.2012 |
Ausbildung von Jeff Macdonald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Washington & Lee University
Washington & Lee University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
















